BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30536429)

  • 1. Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.
    Gernez Y; Baker MG; Maglione PJ
    Transfusion; 2018 Dec; 58 Suppl 3(Suppl 3):3056-3064. PubMed ID: 30536429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Infections in Primary Antibody Deficiencies.
    Demirdag YY; Gupta S
    Front Immunol; 2021; 12():634181. PubMed ID: 33643318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Humoral immunodeficiency : awareness for better support].
    El Bakkouri J; Aadam Z; Ailal F; Alj HS; Bousfiha AA
    Pan Afr Med J; 2014; 18():272. PubMed ID: 25489366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.
    Duraisingham SS; Buckland M; Dempster J; Lorenzo L; Grigoriadou S; Longhurst HJ
    PLoS One; 2014; 9(6):e100324. PubMed ID: 24971644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral infections and inborn errors of immunity.
    Ewing A; Madan RP
    Curr Opin Infect Dis; 2024 May; ():. PubMed ID: 38747352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal and other oral manifestations of immunodeficiency diseases.
    Peacock ME; Arce RM; Cutler CW
    Oral Dis; 2017 Oct; 23(7):866-888. PubMed ID: 27630012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.
    Boisson B; Quartier P; Casanova JL
    Curr Opin Immunol; 2015 Feb; 32():90-105. PubMed ID: 25645939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data.
    Kareva I; Zutshi A; Mateo CV; Papasouliotis O
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):601-611. PubMed ID: 34328632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK PID Patients: Overview of perception on IgRT and infections using short survey.
    Hodkinson JP; Griffiths PR; Narme AMI; Staiger C
    Pharmazie; 2023 Dec; 78(11):231-237. PubMed ID: 38178285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary antibody deficiency - causes and approach to diagnosis.
    Srivastava S; Wood P
    Clin Med (Lond); 2016 Dec; 16(6):571-576. PubMed ID: 27927823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung disease, antibodies and other unresolved issues in immune globulin therapy for antibody deficiency.
    Cunningham-Rundles C
    Clin Exp Immunol; 2009 Sep; 157 Suppl 1(Suppl 1):12-6. PubMed ID: 19630864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When the Good Syndrome Goes Bad: A Systematic Literature Review.
    Shi Y; Wang C
    Front Immunol; 2021; 12():679556. PubMed ID: 34113351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kunkel Lecture: Fundamental immunodeficiency and its correction.
    Nathan C
    J Exp Med; 2017 Aug; 214(8):2175-2191. PubMed ID: 28701368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.
    Giralt S; Jolles S; Kerre T; Lazarus HM; Mustafa SS; Papanicolaou GA; Ria R; Vinh DC; Wingard JR
    Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):719-732. PubMed ID: 37353432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.
    Patel SY; Carbone J; Jolles S
    Front Immunol; 2019; 10():33. PubMed ID: 30800120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and experimental treatment of primary humoral immunodeficiencies.
    Szaflarska A; Lenart M; Rutkowska-Zapała M; Siedlar M
    Clin Exp Immunol; 2024 Apr; 216(2):120-131. PubMed ID: 38306460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework.
    Haas OA
    Front Immunol; 2018; 9():3136. PubMed ID: 30809233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-infectious Pulmonary Complications in Children with Primary Immunodeficiency.
    Mongkonsritragoon W; Srivastava R; Seth D; Navalpakam A; Poowuttikul P
    Clin Med Insights Pediatr; 2023; 17():11795565231196431. PubMed ID: 37692068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary immunodeficiencies with predominant antibody deficiency: multidisciplinary perspectives of Polish experts.
    Jahnz-RÓŻyk K; WiĘsik-Szewczyk E; RoliŃski J; Siedlar M; JĘdrzejczak W; Sydor W; Tomaszewska A
    Cent Eur J Immunol; 2020; 45(3):334-341. PubMed ID: 33437186
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.